CX3CL1 and cancer: In this study we tested expression of CX3CR1 and CX3CL1 in the specimens of normal and pathologic fallopian tube, with the former including specimens of normal oviduct tissue and cancer adjacent normal oviduct tissue, and the latter including specimens of fallopian tube with chronic inflammation and adenocarcinoma of the fallopian tube.